nemene AI is a biotechnology company pioneering the discovery of eIF biomarker relationships by using GenAI Discovery. Founded by leading scientists and AI experts, nemene AI aspires to make people live better and longer by bringing medical research results directly to the service of patients.
Nemene‘s pipeline consists of severity diagnostics solutions for cancer, neurodegenerative diseases and viral infections.
Since nemene’s foundation in 2021, strong partnerships with industry leaders in diagnostics has been established to ensure scalability of the pipeline.
To learn more about nemene reach out to us:
Info@nemene.ai
Company Details
- Founded
- 2021
- Address
- Hohenzell, At
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://nemene.ai/
- Keywords
- Artificial Intelligence, Drug Development, Diagnostics, Scientific Innovation, Machine Learning, BioScience, Deep Learning.
- HQ
- Hohenzell
Nemene Ai Questions
Nemene Ai's website is https://nemene.ai/
Nemene Ai's LinkedIn profile is https://at.linkedin.com/company/nemeneai
Nemene Ai's industry is
Biotechnology Research
Nemene Ai's top competitors are
The Blue Effekkt,
Blickle Group,
Kearney,
Avl,
Advent,
Blueforte,
Palfinger Ag,
Hauck Aufhäuser Lampe Private Markets,
Colgate-Palmolive,
Dataciders Paso.
Nemene Ai's categories are Biotechnology Research
Nemene Ai's founding year is 2021
